The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Open accessAbstract
OBJECTIVE: To determine if differences in morbidity of systemic lupus erythematosus (SLE) as measured by (1) important renal disease, (2) number of hospitalizations, and (3) neurologic disease can be explained by race, socioeconomic status (SES), or measures of compliance. DESIGN: The interrelationship of black race, SES, and the physician's assessment of compliance as risk factors for morbidity was examined in a cohort of 198 patients with SLE (179 female, 115 black). SES was measured with Nam-Powers scores for education (years), income, and job status, and source of insurance; compliance was assessed by physician global assessment and percent of protocol visits kept. Morbidity outcomes were important renal disease (creatinine level 1.5 mg/dL or greater, renal failure, nephrotic syndrome), neurologic involvement, and number of hospitalizations. SETTING: The Johns Hopkins Rheumatology Faculty Practice, in which both private and clinic patients are seen. RESULTS: Black patients had significantly lower SES on all measures (p less than 0.0001) and were also less compliant by physician global assessment (odds ratio [OR] = 0.39, p = 0.002). Univariate analyses showed that blacks had a higher frequency of important renal disease (OR = 2.07, 95% confidence interval [CI] 1.05 to 4.11) and hypertension (OR = 1.80, 95% CI 1.01 to 3.23). Important renal disease was associated with the physician global assessment of compliance (p = 0.009) and hypertension (p less than 0.001). Multiple regression models for important renal disease, including race, physician global assessment of compliance, hypertension, SES, age, and gender, identified significant associations with only physician global assessment of compliance (OR = 0.40, 95% CI 0.17 to 0.91) and hypertension (OR = 5.37, 95% CI 2.40 to 11.98); black race was not significant (OR = 1.60, 95% CI 0.68 to 3.76). The second morbidity measure, number of hospitalizations, was associated with renal disease, neurologic disease, mouth ulcers, duration of disease, and public insurance but not with black race, in the best log-linear model. Neither race, SES variables, nor physician assessment of compliance was significantly associated with neurologic disease, the third morbidity measure. CONCLUSIONS: These data fail to support an independent association of black race with morbidity in SLE; rather, they suggest that noncompliance (as measured by physician global assessment) and type of medical insurance are important factors in morbidity. Classical epidemiologic measures of SES (education, income, occupation) do not appear to be significant confounders of the relationship of race to morbidity in SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Sackett, D. L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90012-2 · Cited by 2,075
THE MEASUREMENT OF SOCIAL CLASS IN EPIDEMIOLOGY
LIBERATOS, P., LINK, B. G., & KELSEY, J. L. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036030 · Cited by 1,335
THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS
ESTES, D., & CHRISTIAN, C. L. (1971) · Medicine · doi:10.1097/00005792-197103000-00001 · Cited by 936
Wallace, D. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-436_2 · Cited by 658
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States.
Lawrence, R. C., Hochberg, M. C., Kelsey, J. L., McDuffie, F. C., Medsger, T. A., Felts, W. R., & Shulman, L. E. (1989) · PubMed · Cited by 505
Self-citationWj, F. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.134.6.1027 · Cited by 429
The epidemiology of systemic lupus erythematosus
Siegel, M., & Lee, S. L. (1973) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(73)90034-6 · Cited by 407
HOCHBERG, M. C., BOYD, R. E., AHEARN, J. M., ARNETT, F. C., BIAS, W. B., PROVOST, T. T., & STEVENS, M. B. (1985) · Medicine · doi:10.1097/00005792-198509000-00001 · Cited by 398
Self-citationA multicenter study of outcome in systemic lupus erythematosus.
Ginzler, E. M., Diamond, H. S., Weiner, M., Schlesinger, M., Fries, J. F., Wasner, C., Medsger, T. A., Ziegler, G., Klippel, J. H., Hadler, N. M., et al. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250601 · Cited by 388
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Management strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
Self-citationTektonidou, M. G., Dasgupta, A., & Ward, M. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39594 · Cited by 582
Alarcón, G. S., McGwin, G., Bertoli, A. M., Fessler, B. J., Calvo-Alén, J., Bastian, H. M., Vilá, L. M., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068676 · Cited by 528
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
Metadata
- Authors
- Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1991-10
- Volume
- 91
- Issue
- 4
- Pages
- 345-353
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2112155656
- Cited by
- 278
- References
- 33
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. https://app.cochat.ai/papers/10.1016/0002-9343(91)90151-m
- The paper
- Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991). Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(91)90151-m
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.